Oncopeptides AB (publ)
ONPPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$283 | -$253 | -$349 | -$1,421 |
| Dep. & Amort. | $0 | $11 | $17 | $15 |
| Deferred Tax | $0 | $0 | -$19 | $34 |
| Stock-Based Comp. | $0 | $0 | $19 | -$34 |
| Change in WC | -$3 | -$56 | -$109 | -$38 |
| Other Non-Cash | $26 | $19 | $21 | -$72 |
| Operating Cash Flow | -$261 | -$279 | -$421 | -$1,516 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$3 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$0 | -$3 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$8 | $116 | $0 | $0 |
| Stock Issued | $313 | $0 | $436 | $1,116 |
| Stock Repurch. | $0 | -$0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$42 | -$9 | -$43 | -$82 |
| Financing Cash Flow | $264 | $107 | $392 | $1,034 |
| Forex Effect | $1 | $2 | $13 | $5 |
| Net Chg. in Cash | $5 | -$171 | -$18 | -$478 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $173 | $345 | $362 | $840 |
| End Cash | $179 | $173 | $345 | $362 |
| Free Cash Flow | -$261 | -$280 | -$423 | -$1,517 |